S.Amdt. 1299Senate117th Congress (2021-2023)2nd degree
S.Amdt. 1299
Sponsored by
Sen. Richard Burr (R-NC)
Submitted March 5, 2021
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
March 5, 2021
Text
Submitted
SA 1299. Mr. BURR submitted an amendment intended to be proposed to amendment SA 891 proposed by Mr. Schumer (for himself, Mr. Wyden, Mrs. Murray, Mr. Brown, Mr. Peters, Mr. Cardin, Ms. Cantwell, Ms. Stabenow, Mr. Tester, Mr. Menendez, Mr. Schatz, Mr. Carper, Mr. Leahy, and Mr. Sanders) to the bill H.R. 1319, to provide for reconciliation pursuant to title II of S. Con. Res. 5; which was ordered to lie on the table; as follows: On page 84, line 9, strike ``to be'' and all that follows through ``COVID-19'' on line 19, page 84 and insert the following: to prevent, prepare for, and respond to COVID-19, domestically or internationally, including the development and review of medical countermeasures to address COVID-19 and emerging variants of COVID-19, and which may be used for the evaluation of the continued performance, safety, and effectiveness, including with respect to emerging COVID-19 variants, of vaccines, therapeutics, and diagnostics approved, cleared, licensed, or authorized for use for the treatment, prevention, or diagnosis of COVID-19; facilitation of advanced continuous manufacturing activities related to production of vaccines and related materials; facilitation and conduct of inspections related to the manufacturing of vaccines, therapeutics, and devices delayed or cancelled for reasons related to COVID-19, including modernizing inspection processes; facilitation of the use of real world evidence and real world data for approved, cleared, licensed, or authorized medical products. ______